A detailed history of Baldwin Investment Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Baldwin Investment Management, LLC holds 22,180 shares of NVO stock, worth $2.42 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
22,180
Previous 22,180 -0.0%
Holding current value
$2.42 Million
Previous $3.17 Million 16.59%
% of portfolio
0.68%
Previous 0.44%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$122.71 - $146.91 $56,569 - $67,725
-461 Reduced 2.04%
22,180 $3.17 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $132,232 - $176,016
-1,295 Reduced 5.41%
22,641 $2.91 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $17,556 - $21,090
200 Added 0.84%
23,936 $2.48 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $1.08 Million - $2.37 Million
11,868 Added 100.0%
23,736 $2.16 Million
Q2 2023

Aug 01, 2023

SELL
$155.98 - $172.65 $48,509 - $53,694
-311 Reduced 2.55%
11,868 $1.92 Million
Q4 2022

Feb 10, 2023

SELL
$102.55 - $135.33 $38,353 - $50,613
-374 Reduced 2.98%
12,179 $1.65 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $37,445 - $45,953
-393 Reduced 3.04%
12,553 $1.25 Million
Q4 2021

Feb 11, 2022

SELL
$95.88 - $117.08 $47,940 - $58,540
-500 Reduced 3.72%
12,946 $1.45 Million
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $24,222 - $30,344
358 Added 2.74%
13,446 $1.13 Million
Q1 2021

May 14, 2021

SELL
$67.06 - $75.82 $32,188 - $36,393
-480 Reduced 3.54%
13,088 $882,000
Q4 2020

Feb 16, 2021

SELL
$63.89 - $73.8 $6,389 - $7,380
-100 Reduced 0.73%
13,568 $948,000
Q2 2020

Jul 27, 2020

BUY
$58.54 - $67.94 $10,888 - $12,636
186 Added 1.38%
13,668 $895,000
Q1 2020

May 12, 2020

SELL
$49.46 - $64.78 $47,234 - $61,864
-955 Reduced 6.61%
13,482 $812,000
Q3 2019

Nov 13, 2019

BUY
$47.54 - $53.43 $14,309 - $16,082
301 Added 2.13%
14,437 $746,000
Q2 2019

Aug 06, 2019

BUY
$46.79 - $52.47 $23,395 - $26,235
500 Added 3.67%
14,136 $722,000
Q4 2018

Feb 13, 2019

BUY
$41.54 - $47.25 $20,770 - $23,625
500 Added 3.81%
13,636 $628,000
Q2 2018

Aug 15, 2018

BUY
$44.29 - $50.42 $225,879 - $257,142
5,100 Added 63.46%
13,136 $606,000
Q1 2018

May 11, 2018

SELL
$48.49 - $58.14 $2,133 - $2,558
-44 Reduced 0.54%
8,036 $396,000
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $3,127 - $3,740
76 Added 0.95%
8,080 $389,000
Q2 2017

Aug 08, 2017

BUY
N/A
8,004
8,004 $343,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $246B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Baldwin Investment Management, LLC Portfolio

Follow Baldwin Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Investment Management, LLC with notifications on news.